Company / Interest Expense
Astria Therapeutics, Inc. Interest Expense History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$100.0K
FY2018
5-year range
-
FY2015-FY2018
Trend
-78.4%
vs FY2017
Sector context
#38 of 44
Health Care
What the data says
Astria Therapeutics, Inc.'s interest expense of $100,000 is lower than 86% of companies in the Health Care sector (FY2018). Interest Expense has declined for 3 consecutive years, from $978,000 in FY2015 to $100,000 in FY2018.
Based on SEC 10-K filings.
$100,000 in FY2018 with a 3-year CAGR of -53.2%.
Improved from $837,000 to $100,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -53.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $100.0K Sector average $291.0M
▼
-100.0% below sector average
Key checks
Key Insights
- Astria Therapeutics, Inc.'s interest expense has declined for 3 consecutive years.
- 3-year CAGR of -53.2%, indicating a declining trend.
- In FY2018, interest expense decreased 78.4% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $100.0K | -78.4% |
| FY2017 | $462.0K | -44.8% |
| FY2016 | $837.0K | -14.4% |
| FY2015 | $978.0K | +374.8% |
As of FY2018 · SEC 10-K · Updated Feb 28, 2026